P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION.

Documenti analoghi

• P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION.
  di: C. C. Kockerols, et al.
  Pubblicazione: (2022-06-01)
• Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice
  di: Camille C.B. Kockerols, et al.
  Pubblicazione: (2020-12-01)
• The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era
  di: Camille C.B. Kockerols, et al.
  Pubblicazione: (2022-03-01)
• New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia
  di: Peter E. Westerweel, et al.
  Pubblicazione: (2019-08-01)
• P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE
  di: A. Innes, et al.
  Pubblicazione: (2022-06-01)